Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)

ClinicalTrials.gov ID: NCT03068754

Public ClinicalTrials.gov record NCT03068754. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 12:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

About 213 people with ALS will participate in this study. There will be locations in North and South America. During the first part, participants will be randomly assigned to a group (like by flipping a coin). Out of every 3: * 2 will get the study drug * 1 will get a look-alike with no drug in it (placebo) During the second part, everyone will get the study drug. Participation will help doctors find out if Acthar can help or slow down the symptoms of ALS better than placebo.

Study identification

NCT ID
NCT03068754
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Mallinckrodt
Industry
Enrollment
143 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2017 (Actual)
Primary completion
Nov 25, 2019 (Actual)
Completion
Nov 25, 2019 (Actual)
Last update posted
Oct 14, 2020

2017 – 2019

United States locations

U.S. sites
39
U.S. states
24
U.S. cities
36
Facility City State ZIP Site status
Neuromuscular Research Center Phoenix Arizona 85028 —
Mayo Clinic - Arizona Scottsdale Arizona 85259 —
University of California San Diego La Jolla California 92037 —
Loma Linda University Health System, Department of Neurology Loma Linda California 92354 —
Keck School of Medicine, University of Southern California Los Angeles California 90033 —
University of California Los Angeles Los Angeles California 90095 —
University of California Irvine Medical Center Orange California 92868 —
California Pacific Medical Center San Francisco California 94115 —
University of California San Francisco San Francisco California 94143 —
Colorado Springs Neurological Associates Colorado Springs Colorado 80907 —
Georgetown University Washington D.C. District of Columbia 20007 —
George Washington University Washington D.C. District of Columbia 20037 —
University of Florida - McKnight Brain Institute Gainesville Florida 32611 —
University of South Florida Tampa Florida 33612 —
Emory University Atlanta Georgia 30322 —
Augusta University Augusta Georgia 30912 —
Indiana University-Neuroscience Center of Excellence/Goodman Hall Indianapolis Indiana 46202 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Kentucky Chandler Medical Center Lexington Kentucky 40536 —
John Hopkins Outpatient Center Baltimore Maryland 21287 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
Mercy Health- Saint Mary's Grand Rapids Michigan 49503 —
Neurology Associates Lincoln Nebraska 68510 —
University of Nebraska Medical Center - Physicians Clinical Neurosciences Center Omaha Nebraska 68198 —
Las Vegas Clinic Las Vegas Nevada 89145 —
Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Columbia Presbyterian Hospital New York New York 10032 —
Providence ALS Center Portland Oregon 97213 —
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Temple University School of Medicine Philadelphia Pennsylvania 19140 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Wesley Neurology Clinic Cordova Tennessee 38018 —
Austin Neuromuscular Center Austin Texas 78756 —
Texas Neurology, P.A. Dallas Texas 75214 —
The Methodist Hospital Houston Texas 77030 —
University of Vermont Medical Center Colchester Vermont 05401 —
VCU Medical Center Richmond Virginia 23298 —
Swedish Neuroscience Institute Seattle Washington 98122 —
Medical College of Wisconsin/Froedtert Hospital Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03068754, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03068754 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →